Flexion Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference
03 June 2021 - 6:30AM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that
Michael Clayman, M.D., President and Chief Executive Officer, will
participate in an analyst-led fireside chat at the Goldman Sachs
42nd Annual Global Healthcare Virtual Conference. The virtual
fireside chat is scheduled to begin at 3:50 p.m. ET on
Tuesday, June 8, 2021.
To access the live webcast and subsequent archived recording of
the presentation, please visit the Flexion website
at http://ir.flexiontherapeutics.com.
About Flexion TherapeuticsFlexion Therapeutics
(Nasdaq:FLXN) is a biopharmaceutical company focused on the
development and commercialization of novel, local therapies for the
treatment of people with musculoskeletal conditions, beginning with
osteoarthritis, the most common form of arthritis. The Company's
core values are focus, ingenuity, tenacity, transparency and fun.
Please visit flexiontherapeutics.com.
Contact:
Scott YoungVice President, Corporate Communications &
Investor RelationsFlexion Therapeutics, Inc.T:
781-305-7194syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Apr 2024 to May 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Flexion Therapeutics Inc (NASDAQ): 0 recent articles
More News Articles